Radiotherapy and theranostics: a Lancet Oncology Commission

Radiotherapy and theranostics: a Lancet Oncology Commission

In the 2015 Lancet Oncology Commission on expanding global access to radiotherapy, disparities in the availability of radiotherapy machines...
1 day ago
from: The Lancet

Continue reading...
Cancer treatment, Medicine, Oncology, Radiation therapy
More about this
- Radiotherapy and theranostics: a Lancet Oncology Commission
In the 2015 Lancet Oncology Commission on expanding global access to radiotherapy, disparities in the availability of radiotherapy machines...
from: The Lancet
- Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b. Hypofractionation could expand...
from: Healthcare Asia Magazine
- Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.
from: Healthcare Asia Magazine